logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/05/2025
Jones Trading: Maintains Buy rating on Enliven Therapeutics (ELVN.US), adjusted from Buy to Buy rating, target price adjusted from $36.00 to $27.00.
Latest
2 m ago
The Chinese Consulate-General in San Francisco reminds Chinese citizens to pay attention to U.S. entry requirements and strengthen security precautions.
3 m ago
France sees a resurgence of kidnapping plots targeting cryptocurrency tycoons.
3 m ago
Guanghong Technology: The company's Shenzhen Pingshan Intelligent Manufacturing Park is expected to be gradually put into use by the middle of this year.
3 m ago
Swedish police: The suspect's motive in the school shooting case does not involve racism.
6 m ago
CITIC Securities evaluates AI+ Enterprise Management: Agent Core, Leading Benefits
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.